According to Novo Nordisk, a 64-week clinical trial with over 300 participants found that those with obesity or overweight who took the oral Wegovy pill once a day lost an average of 16.6% of their body weight for people who completed the trial, a similar amount to those who took the injectable form of Wegovy, which launched in 2021, on a weekly basis
Why We Still Treat Type 2 Diabetes Like Its 1995 Doctors have been treating diabetes the same way for decades
Heart Disease Consult your doctor Individuals with heart conditions should consult their doctor before use, especially if they are on long-term medications
Side effects that are rare, delayed, or cumulative may not yet be identified
Whether you are comparing semaglutide versus tirzepatide , calculating your semaglutide dosage , or researching peptides for fat loss , the tools are there to support informed decisions at every stage of the protocol